Decode Health, Spesana announce strategic partnership
The alliance links Nashville and Memphis companies in an alliance to propel the advancement of precision medicine and transform digital health.
Decode Health and Spesana, two leading health tech companies based in Tennessee, have announced a strategic partnership that promises to propel the advancement of precision medicine and transform digital health.
By combining Decode Health’s artificial intelligence (AI) and machine learning expertise with Spesana’s clinical workflow solutions, the partnership aims to revolutionize patient care and outcomes in the healthcare industry. Through this collaboration, clinicians will have unprecedented access to actionable data at the point of care, empowering them to make informed decisions and create more efficient and personalized patient treatment plans.
Decode Health’s state-of-the-art data platform and analytics capabilities will seamlessly integrate with Spesana’s point-of-care solution, providing a comprehensive suite of cutting-edge tools and insights. The collaboration is driven by the shared objectives the two companies have and their strong alignment in mission, vision, and values. Both are deeply committed to advancing healthcare technology and improving patient outcomes. Additionally, their presence in the Tennessee start-up community makes this partnership a local success story for the region.
Decode Health is a Nashville-based company that delivers a data platform to accelerate precision medicine and improve the efficiency of pharma research and development using AI and machine learning. We have spotlighted its growth in several teknovation.biz articles, the most recent being in April 2023. Spesana, located in Memphis, has developed a healthcare platform for all therapeutic areas in all care settings to increase the velocity of patients moving to the right specialists with a unified medical record. Important to the mission is the focus on precision medicine, notably molecular diagnostics, and clinical collaborations to allow physicians, patients, and insurance teams to come together around the best available therapies and new clinical trials for patients.
Click here to read the full news release.